1 / 62

Medical stability & Substance related emergencies

Medical stability & Substance related emergencies. M. Nadeem Mazhar MBBS, MRCPsych , FRCPC, DABPN. Objectives. Review issues regarding “medical clearence” in ED Assess common medical causes of agitation Evaluate assessment substance related emergencies. “Medical clearance”.

joellenc
Download Presentation

Medical stability & Substance related emergencies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Medical stability & Substance related emergencies M. NadeemMazhar MBBS, MRCPsych, FRCPC, DABPN

  2. Objectives • Review issues regarding “medical clearence” in ED • Assess common medical causes of agitation • Evaluate assessment substance related emergencies

  3. “Medical clearance”

  4. Medical clearance “There is no way to rule out every possible medical illness a patient may have prior to admission to a psychiatric unit” (Zun 2005)

  5. Medical stability Making a reasonable investigation to exclude the possibility of patient having an illness that: • Would be better treated in a medical setting (e.g., infection requiring IV antibiotics) • Will cause the acute decompensation in the next few hours requiring a higher level of care (e.g., severe alcohol withdrawal) • Causing behavioral symptoms but should be treated by something other than psychiatric medications (e.g., delirium due to an underlying infection) • Worsening the psychiatric process (e.g., untreated pain that is causing the agitation) (Clinical Manual of Emergency Psychiatry)

  6. Physical examination • Evaluation of patient’s general medical status necessitates that a physical examination be performed • Physical examination may be performed by the psychiatrist, another physician, or a medically trained clinician • Particular caution in examination of patients with histories of sexual abuse- “All but limited examination of such patients should be chaperoned” (APA Practice Guidelines for Psychiatric Evaluation of Adults- second edition, 2006)

  7. Physical examination Specific elements may include the following: • General appearance, height, weight, BMI & nutritional status • Vital signs • Head and neck, heart, lungs, abdomen, and extremities • Neurological status, including cranial nerves, motor and sensory function, gait, coordination, muscle tone, reflexes, and involuntary movements • Skin e.g., stigmata of self injury or drug use • Any body area or organ system specifically mentioned in the HPI or ROS (APA Practice Guidelines for Psychiatric Evaluation of Adults- second edition, 2006)

  8. General appearance • Cachexia- suspicion of cancer, HIV, TB, malnutrition • Obvious respiratory distress • Obvious physical distress or agitation • Grossly dishevelled or malodorous patient • Rashes- allergic or infectious diseases

  9. HEENT • Dry mucous membranes- dehydration • Pupils and eye movements- focal neurological deficits, evidence of drug intoxication/withdrawal • Scleral icterus- jaundice • Proptosis- hyperthyroidism • Bruises, lacerations- evidence of head/facial trauma • Poor dentition- nutritional status

  10. Neck • Thyromegaly- goiter, hyperthyroidism • Neck rigidity- meningitis, encaphalitis

  11. Chest • Rales- congestive heart failure • Rhonchi- pneumonia

  12. Cardiovascular • Rate, rhythm, regularity of heartbeat • Vascular disease- any absent peripheral pulses

  13. Abdomen • Hepatomegaly- undiagnosed liver disease • Acute tenderness- acute pathology that needs to be addressed in ED

  14. Extremities • Any deficits, limps or pain

  15. Neurological • Any focal deficits indicating stroke • Festinating gait, rigidity- parkinsonism • Tremors- EPSE, Parkinson’s disease • Broad based gait- hydrocephalus, tertiary syphilis • Evidence of tardive dyskinesia

  16. Diagnostic tests in Psychiatry • Detect or rule out presence of condition that has treatment consequences • Determine the relative safety and appropriate dose of potential alternative treatments • Provide baseline measurements before instituting treatment • Monitor blood levels of medication when indicated (APA Practice Guidelines for Psychiatric Evaluation of Adults- second edition, 2006)

  17. Laboratory tests CBC: • Macrocytic anemia- vitamin B12/folate deficiency, alcohol abuse • Microcytic anemia- iron deficiency • Normocytic anemia- acute bleeding or chronic inflammatory disease • Leukocytosis- acute infection • Leukopenia- advanced HIV disease, leukemia, carbamazepine • Low platelets- Valproate, ITP

  18. Laboratory tests Electrolytes & Creatinine: • Elevated creatinine- renal failure • Hyponatremia- SSRI’s • Hypernatremia- dehydration, renal failure • Hypokalemia- risk for arrhythmia, bulimia, diuretic use • Hyperkalemia- risk for arrhythmia, renal failure • Low bicarbonate- acidosis, aspirin ingestion

  19. Laboratory tests Liver enzymes: • Elevated AST: ALT ratio- alcohol abuse • Elevated ALT & AST: liver failure due to multiple causes e.g., acetaminophen ingestion, hepatitis

  20. Laboratory tests TSH: • Elevated- hypothyroidism leading to depression, cognitive changes • Low- hyperthyroidism leading to manic like symptoms, agitation

  21. Laboratory tests Vitamin B12 & Folate: • Low B12- neurological changes, memory problems • Low folate- evidence of general malnutrition, association with depression

  22. Laboratory tests • Syphilis serology/HIV testing • Medication levels • Blood alcohol levels • Fasting blood glucose or hemoglobin A1c • Pregnancy test • Urinalysis • Urine drug screen

  23. Other investigations Chest X-ray: Considered for all homeless people, any patients with suspicion of TB, and elderly patients Head CT: In patients with altered mental status or new-onset psychosis- to rule out SOL or bleeding EEG: Evidence of metabolic encephalopathy (delirium), nonconvulsive status epilepticus ECG: Medications that may influence cardiac function Lumbar puncture: Any patient with new mental status changes, fever, and/or meningeal signs- to rule out meningitis, encephalitis, bleeding, cryptococcal infection

  24. Agitation- medical causes Delirium: • Waxing and waning level of consciousness • Fluctuation in vital signs • Confusion • Can be irritable or passive and detached • More common in elderly

  25. Agitation- medical causes Hypogylcemia: • Altered mental status • Sweating • Tachycardia • Weakness

  26. Agitation- medical causes Post-ictal states: • Altered level of consciousness • Confusion • Ataxia • Todd paralysis • Neurological signs such as slurred speech • Evidence of tongue biting or incontinence

  27. Agitation- medical causes Structural brain abnormality: • Varies by lesion • Altered mental status • Headache • Meningeal signs • Focal neurological deficit or progressive neurological deterioration

  28. Agitation- medical causes Toxicologic emergency: • Varies by substance • Mental status changes • Pupillary changes • Vital sign changes • Sweating

  29. Substance Related psychiatric emergencies

  30. Initial evaluation • Thorough history using available resources • MSE • Physical examination • Laboratory tests • Imaging studies • Urine drug detection- ELISA, gas chromatography- mass spectrometry

  31. The depressed patient MSE suggestive of depression or psychomotor slowing: • Alcohol intoxication • Sedative-hypnotic toxicity • Opioid toxicity • OTC cough & cold medication • Inhalant intoxication • CNS stimulants withdrawal

  32. Alcohol intoxication • Most common cause of substance related emergencies • Studies showing up to 40% of ED patients having alcohol detected in their blood • CNS depressant effect by increasing responsivity of GABA type A receptors to GABA and inhibiting effects of glutamate at its receptors • Disinhibition at onset resulting agitation, combativeness and rarely psychosis • Dose-dependent CNS depression: Diminished coordination→ slurred speech/ataxia→ respiratory depression/coma • Legal limit: 0.05%- 0.08% (50mg/dl – 80mg/dl or 10.85 mmol/L – 17.36 mmol/L)

  33. Alcohol intoxication • Treatment of alcohol intoxication- supportive • Gastric lavage not useful due to rapid absorption of alcohol from gastrointestinal tract • Serial monitoring of toxic blood alcohol levels for expected gradual drop • Chronic alcoholics metabolize ETOH at a rate of 15-20 mg/dl per hour • In case of persistent alteration in consciousness→ exclude other causes e.g., other toxins, metabolic dysfunction or subdural hematoma

  34. Sedative-hypnotic toxicity • Can occur in acute overdoses, patients exceeding scheduled doses or with concomitant administration of other CNS depressants • Accumulation can also result in liver disease, advanced age and pharmacokinetic drug interactions • Temazepam, oxazepam, lorazepam & alprazolam metabolized primarily by conjugation- less likely to accumulate in liver impairment • Dose dependent effects on coordination, cognition and consciousness • Paradoxical agitation/excitement can also result from drug induced disinhibition

  35. Sedative-hypnotic toxicity • Vomiting, diarrhea and urinary retention can occur in BZD toxicity • Flumazenil ≤ 1mg reverses BZD effects- may precipitate seizures in dependent individuals • BZD’s rarely lethal by themselves • Synergism with other CNS depressants e.g., alcohol & opioids • Can worsen ventilation in patients with preexisting cardio-respiratory conditions e.g., OSA, COPD & CHF • High index of suspicion in patients with history of ETOH abuse • BZD misuse also likely in patients on opioids & cocaine users

  36. Opioid toxicity • Miosis + CNS & respiratory depression • Slow, shallow respiration, absent GI sounds & urinary retention • Toxicity can also result from acetaminophen or NSAIDs frequently combined with prescription opioids • Naloxone is a specific antidote→ can precipitate opioid withdrawal • Repeated doses may be required due to naloxone’s short half life

  37. OTC cold & cough medications • Frequently abused by adolescents to get “high” • May contain mixtures of various antihistamines, sympathomimetics with or without dextromethorphan • Difficult to detect in urine→ pseudoephedrine may screen positive for amphetamine

  38. Inhalant intoxication • Include a variety of hydrocarbons including toxic solvents • Initial stage of disinhibition, excitement, or a sense of drunkenness→ restlessness, ↓consciousness, ataxia, respiratory depression, coma and death with ↑inhaled concentrations • Risk of arrhythmias, possible hepatic injury and long-term effects on cognition

  39. CNS stimulant withdrawal • The cocaine “crash” • Dysphoria that may be accompanied by suicidal ideation, sleep disturbance and cravings • Increased appetite as a rebound to appetite-suppressant effects of stimulants

  40. Agitated, aggressive & psychotic patient Agitated behavior ranging from belligerence to physical aggression to full blown psychosis: • Alcohol withdrawal • Sedative-hypnotic withdrawal • Opioid withdrawal • CNS stimulant intoxication • Hallucinogen intoxication • Marijuana intoxication

  41. Alcohol withdrawal • Combativeness and aggression could be seen in both alcohol intoxication and withdrawal • BAL at which withdrawal occurs varies from patient to patient • Can begin in as little as 6 hours from the last drink • Autonomic instability: ↑BP, tachycardia & sweating • GI symptoms: Nausea, vomiting & diarrhea • CNS activation: Anxiety & tremor • Serious withdrawal: Hallucinations & seizures • Delirium tremens: After 48-72 hours, about 5% of patients in alcohol withdrawal, develop DTs- hallucinations (usually visual), delirium and severe autonomic instability

  42. Alcohol withdrawal & CIWA 1) Nausea and vomiting: 0-7 score 2) Tremor: 0-7 3) Paroxysmal sweats: 0-7 4) Anxiety: 0-7 5) Agitation: 0-7 6) Tactile disturbances: 0-7 7) Auditory disturbances: 0-7 8) Visual disturbances: 0-7 9) Headache: 0-7 10) Orientation: 0-4

  43. CIWA & Medication

  44. Structured medication regimens 1) Chlordiazepoxide: • 50 mg Q6H X 4 • Followed by 25 mg Q6H X 8 2) Diazepam: • 10 mg Q6H X 4 • Followed by 5 mg Q6H X 8 3) Lorazepam: • 2 mg Q6h X 4 • Followed by 1 mg Q6H X 8 4) Carbamazepine: • 400 mg BID on day 1 • Tapering down to 200 mg as a single dose on day 5

  45. Pharmacological treatment of alcohol withdrawal • Benzodiazepines • Anticonvulsants • Beta- blocking agents • Alpha-adrenergic agonists • Thiamine • Neuroleptic agents

  46. Sedative-hypnotic withdrawal • Occurs within the first few hours to days after discontinuation following a period of regular use • Similar to alcohol withdrawal except: extended over days to weeks (instead of hours to days) • Anxious prodrome→ tremor, tachycardia, hypertension, diaphoresis, GI upset, mydriasis, sleep disturbance & nightmares, tinnitus, ↑sensitivity to sound, light & tactile stimuli • Confusion, delirium, hyperthermia & GTCS can occur in severe withdrawal • Significant anxiety, sleep disturbance and mild autonomic symptoms may persist for many months

  47. Sedative-hypnotic withdrawal • Switch to longer acting agent & gradually taper (10%/week) • Carbamazepine 200 mg t.i.d. for 7-10 days (gabapentin and divalproex are alternatives)

  48. Opioid withdrawal • Heralded by anxiety, craving/preoccupation & vague discomfort (hyperalgesia) • Pupillary dilatation, lacrimation, rhinorrhea, diaphoresis, piloerection, arthralgia/myalgia, diarrhea, yawning & sneezing • Rarely causes change in mental status except for ↑anxiety • Onset: 6-72 hours after last use/dose • Peak: 2-4 days • Resolution: 7-10 days • Not life threatening in otherwise healthy patient • Miscarriage in pregnancy

  49. Clinical Opiate Withdrawal Scale (COWS) • Resting pulse rate (0-4 score) • Sweating (0-4 score) • Restlessness (0-5 score) • Pupil size (0-5 score) • Bone or Joint aches (0-4 score) • Runny nose or tearing (0-4 score) • GI upset (0-5 score) • Tremor (0-4 score) • Yawning (0-4 score) • Anxiety or irritability (0-4 score) • Gooseflesh skin (0-5 score) • Severity of withdrawal: 5-12= mild, 13-24= moderate, 25-36= moderately severe, >36= severe

  50. Opioid withdrawal treatment CPSO MMT Guidelines-2011

More Related